A citation-based method for searching scientific literature


List of co-cited articles
840 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.
Dai Fukumura, Jonas Kloepper, Zohreh Amoozgar, Dan G Duda, Rakesh K Jain. Nat Rev Clin Oncol 2018
588
19

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
17



Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy.
Yuhui Huang, Jianping Yuan, Elda Righi, Walid S Kamoun, Marek Ancukiewicz, Jean Nezivar, Michael Santosuosso, John D Martin, Margaret R Martin, Fabrizio Vianello,[...]. Proc Natl Acad Sci U S A 2012
533
15

Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming.
Lin Tian, Amit Goldstein, Hai Wang, Hin Ching Lo, Ik Sun Kim, Thomas Welte, Kuanwei Sheng, Lacey E Dobrolecki, Xiaomei Zhang, Nagireddy Putluri,[...]. Nature 2017
332
14

Vascular normalization as an emerging strategy to enhance cancer immunotherapy.
Yuhui Huang, Shom Goel, Dan G Duda, Dai Fukumura, Rakesh K Jain. Cancer Res 2013
356
12


Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels.
Vikash P Chauhan, John D Martin, Hao Liu, Delphine A Lacorre, Saloni R Jain, Sergey V Kozin, Triantafyllos Stylianopoulos, Ahmed S Mousa, Xiaoxing Han, Pichet Adstamongkonkul,[...]. Nat Commun 2013
500
11

Basic and therapeutic aspects of angiogenesis.
Michael Potente, Holger Gerhardt, Peter Carmeliet. Cell 2011
10

PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.
Muhammad Zaeem Noman, Giacomo Desantis, Bassam Janji, Meriem Hasmim, Saoussen Karray, Philippe Dessen, Vincenzo Bronte, Salem Chouaib. J Exp Med 2014
9

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
Richard S Finn, Shukui Qin, Masafumi Ikeda, Peter R Galle, Michel Ducreux, Tae-You Kim, Masatoshi Kudo, Valeriy Breder, Philippe Merle, Ahmed O Kaseb,[...]. N Engl J Med 2020
9

Normalization of the vasculature for treatment of cancer and other diseases.
Shom Goel, Dan G Duda, Lei Xu, Lance L Munn, Yves Boucher, Dai Fukumura, Rakesh K Jain. Physiol Rev 2011
933
9

Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages.
Teresa E Peterson, Nathaniel D Kirkpatrick, Yuhui Huang, Christian T Farrar, Koen A Marijt, Jonas Kloepper, Meenal Datta, Zohreh Amoozgar, Giorgio Seano, Keehoon Jung,[...]. Proc Natl Acad Sci U S A 2016
170
9

Microenvironmental regulation of tumour angiogenesis.
Michele De Palma, Daniela Biziato, Tatiana V Petrova. Nat Rev Cancer 2017
754
8

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.
Marta Pàez-Ribes, Elizabeth Allen, James Hudock, Takaaki Takeda, Hiroaki Okuyama, Francesc Viñals, Masahiro Inoue, Gabriele Bergers, Douglas Hanahan, Oriol Casanovas. Cancer Cell 2009
8


Improving immune-vascular crosstalk for cancer immunotherapy.
Yuhui Huang, Betty Y S Kim, Charles K Chan, Stephen M Hahn, Irving L Weissman, Wen Jiang. Nat Rev Immunol 2018
157
8

Increased vessel perfusion predicts the efficacy of immune checkpoint blockade.
Xichen Zheng, Zhaoxu Fang, Xiaomei Liu, Shengming Deng, Pei Zhou, Xuexiang Wang, Chenglin Zhang, Rongping Yin, Haitian Hu, Xiaolan Chen,[...]. J Clin Invest 2018
74
10

Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner.
Vikash P Chauhan, Triantafyllos Stylianopoulos, John D Martin, Zoran Popović, Ou Chen, Walid S Kamoun, Moungi G Bawendi, Dai Fukumura, Rakesh K Jain. Nat Nanotechnol 2012
641
8

Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges.
John D Martin, Giorgio Seano, Rakesh K Jain. Annu Rev Physiol 2019
140
8

Tumor angiogenesis: causes, consequences, challenges and opportunities.
Roberta Lugano, Mohanraj Ramachandran, Anna Dimberg. Cell Mol Life Sci 2020
281
8


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
8

Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors.
Gregory T Motz, Stephen P Santoro, Li-Ping Wang, Tom Garrabrant, Ricardo R Lastra, Ian S Hagemann, Priti Lal, Michael D Feldman, Fabian Benencia, George Coukos. Nat Med 2014
479
8

Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade.
Martina Schmittnaegel, Nicolò Rigamonti, Ece Kadioglu, Antonino Cassará, Céline Wyser Rmili, Anna Kiialainen, Yvonne Kienast, Hans-Joachim Mueller, Chia-Huey Ooi, Damya Laoui,[...]. Sci Transl Med 2017
277
8

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
Mark A Socinski, Robert M Jotte, Federico Cappuzzo, Francisco Orlandi, Daniil Stroyakovskiy, Naoyuki Nogami, Delvys Rodríguez-Abreu, Denis Moro-Sibilot, Christian A Thomas, Fabrice Barlesi,[...]. N Engl J Med 2018
8

Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy.
Anna Rita Cantelmo, Lena-Christin Conradi, Aleksandra Brajic, Jermaine Goveia, Joanna Kalucka, Andreas Pircher, Pallavi Chaturvedi, Johanna Hol, Bernard Thienpont, Laure-Anne Teuwen,[...]. Cancer Cell 2016
293
7

Angiogenesis in cancer and other diseases.
P Carmeliet, R K Jain. Nature 2000
7

Modes of resistance to anti-angiogenic therapy.
Gabriele Bergers, Douglas Hanahan. Nat Rev Cancer 2008
7

Defining the role of the tumor vasculature in antitumor immunity and immunotherapy.
Marco B Schaaf, Abhishek D Garg, Patrizia Agostinis. Cell Death Dis 2018
222
7

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells.
D I Gabrilovich, H L Chen, K R Girgis, H T Cunningham, G M Meny, S Nadaf, D Kavanaugh, D P Carbone. Nat Med 1996
7

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Brian I Rini, Elizabeth R Plimack, Viktor Stus, Rustem Gafanov, Robert Hawkins, Dmitry Nosov, Frédéric Pouliot, Boris Alekseev, Denis Soulières, Bohuslav Melichar,[...]. N Engl J Med 2019
7


Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
Rakesh R Ramjiawan, Arjan W Griffioen, Dan G Duda. Angiogenesis 2017
288
7

Vascular regulation of antitumor immunity.
Lance L Munn, Rakesh K Jain. Science 2019
64
10

VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.
Thibault Voron, Orianne Colussi, Elie Marcheteau, Simon Pernot, Mevyn Nizard, Anne-Laure Pointet, Sabrina Latreche, Sonia Bergaya, Nadine Benhamouda, Corinne Tanchot,[...]. J Exp Med 2015
508
7

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.
Alan Sandler, Robert Gray, Michael C Perry, Julie Brahmer, Joan H Schiller, Afshin Dowlati, Rogerio Lilenbaum, David H Johnson. N Engl J Med 2006
7

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.
Frank Winkler, Sergey V Kozin, Ricky T Tong, Sung-Suk Chae, Michael F Booth, Igor Garkavtsev, Lei Xu, Daniel J Hicklin, Dai Fukumura, Emmanuelle di Tomaso,[...]. Cancer Cell 2004
958
7

Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma.
Kohei Shigeta, Meenal Datta, Tai Hato, Shuji Kitahara, Ivy X Chen, Aya Matsui, Hiroto Kikuchi, Emilie Mamessier, Shuichi Aoki, Rakesh R Ramjiawan,[...]. Hepatology 2020
104
7

Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma.
Yanxia Zhao, Jinghong Cao, Alexander Melamed, Michael Worley, Allison Gockley, Dennis Jones, Hadi T Nia, Yanling Zhang, Triantafyllos Stylianopoulos, Ashwin S Kumar,[...]. Proc Natl Acad Sci U S A 2019
85
8


Antiangiogenic therapy in oncology: current status and future directions.
Gordon C Jayson, Robert Kerbel, Lee M Ellis, Adrian L Harris. Lancet 2016
449
7

Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients.
Sara M Tolaney, Yves Boucher, Dan G Duda, John D Martin, Giorgio Seano, Marek Ancukiewicz, William T Barry, Shom Goel, Johanna Lahdenrata, Steven J Isakoff,[...]. Proc Natl Acad Sci U S A 2015
137
7

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.
Napoleone Ferrara, Kenneth J Hillan, Hans-Peter Gerber, William Novotny. Nat Rev Drug Discov 2004
6

Cancer immunotherapy using checkpoint blockade.
Antoni Ribas, Jedd D Wolchok. Science 2018
6

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Robert J Motzer, Konstantin Penkov, John Haanen, Brian Rini, Laurence Albiges, Matthew T Campbell, Balaji Venugopal, Christian Kollmannsberger, Sylvie Negrier, Motohide Uemura,[...]. N Engl J Med 2019
6

Role of hypoxia in cancer therapy by regulating the tumor microenvironment.
Xinming Jing, Fengming Yang, Chuchu Shao, Ke Wei, Mengyan Xie, Hua Shen, Yongqian Shu. Mol Cancer 2019
353
6



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.